The “Build-to-Buy”Framework Three parties are used: (a) a science company with a novel technology, (b) a venture capital firm and (c) a big pharma company. All parties must agree on a pre-set acquisition price for (a). This is the hardest part. (c) retains an exclusive option to purchase (a) at the pre-set price when a …
First-in-man Somebody’s got to be the first, the pioneer, the risk taker. Two publicly traded companies, Genvec (NASDAQ:GNVC) and its big pharma partner, Novartis (NYSE:NVS) have taken on this moniker. Genvec is a pioneer in the design, testing and manufacture of viral vectors (adenoviral-based products) and Novartis is a big pharma company with the money …
AUGUST 2018: Rescue Hearing Inc (RHI) has signed a Sponsored Research Agreement with the University of Kansas Medical Center Research Institute. RHI will be conducting research to develop gene therapies for hearing loss in the lab of Dr. Hinrich Staecker. Dr. Staecker is a scientific advisor to RHI and he is known for multiple clinical …
July 18, 2018: Rescue Hearing Inc (RHI) has signed a Sponsored Research Agreement with Massachusetts Eye and Ear. RHI will be conducting research to develop gene therapies for hearing loss in the lab of Dr. Zheng-Yi Chen. Dr. Chen is a scientific advisor to RHI and an Associate Professor of Otolaryngology at Harvard Medical School. …
Rescue Hearing signs Sponsored Research Agreement with Mass Eye and Ear Read More »
© Copyright 2022 Rescue Hearing Inc.. All rights reserved.
